Publication | Closed Access

Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10

Regenerative MedicineCell TherapyTransplantationAutoimmune DiseaseStem Cell TransplantationImmunologyInterleukin 10AutoimmunityCell BiologyMesenchymal Stem CellImmunotherapyMedicineCell TransplantationGraft Rejection